Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aavogen
AddedFeb 16, 2024
UpdatedJun 18, 2026
Aavogen

Aavogen

Seed

US-based AAVogen, a biotech startup, innovates gene therapeutics for muscle wasting diseases.

HQ
Rockville, MD, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

AAVogen, a biotech startup based in Rockville, United States, specializes in developing gene therapeutics for muscle wasting diseases. The company focuses on utilizing AAV (Adeno-Associated Virus) vectors, considered the gold standard in gene therapy, to introduce payload genes into tissues with precision. AAVogen's primary target is inclusion body myositis, with additional focus on Duchenne muscular dystrophy.

The company's innovative approach leverages the safety and efficacy of AAV vectors, which have demonstrated a strong safety record in clinical trials. AAVogen aims to provide long-term relief for genetic and chronic diseases, particularly those affecting muscle health. Their work in gene therapy represents a significant step forward in addressing previously untreatable muscle wasting conditions.

Aavogen - Similar Companies

Apertura Gene Therapy logo

Apertura Gene Therapy

aperturagtx.com

Kate Therapeutics logo

Kate Therapeutics

Affinia Therapeutics logo

Affinia Therapeutics

affiniatx.com

BioViva logo

BioViva

Agtc logo

Agtc

beacontx.com

Exegenesis Bio logo

Exegenesis Bio

exegenesisbio.com

Avexegen Therapeutics logo

Avexegen Therapeutics

Lacerta Therapeutics logo

Lacerta Therapeutics

Dyno Therapeutics logo

Dyno Therapeutics

dynotx.com

Genascence logo

Genascence

genascence.com

NabGen logo

NabGen

nabgen.com

Chameleon Biosciences logo

Chameleon Biosciences

Bedrock Therapeutics logo

Bedrock Therapeutics

Synvivia logo

Synvivia

synvivia.com

Amplo Biotechnology logo

Amplo Biotechnology

Aavogen - Quick Facts

Who are Aavogen's competitors?

Companies similar to Aavogen include Apertura Gene Therapy, Kate Therapeutics, Affinia Therapeutics and BioViva.

When was Aavogen founded?

Aavogen was founded in 2015.

Where is Aavogen's headquarters located?

Aavogen's headquarters is located in Rockville, MD, US.

When was Aavogen's last funding round?

Aavogen's most recent funding round was for $400k (USD) in October 2022.

How much has Aavogen raised to-date?

As of Oct 1, 2022, Aavogen has raised a total of $4.7M (USD).

How many employees does Aavogen have?

Aavogen has 5 employees as of Feb 4, 2024.

Aavogen - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Gene Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified